From sequence → stable expression → scalable production
success rate
scale production
turnaround
Not random integration. Not unstable expression. Engineered. Controlled. Scalable.
High yield, Industrial scalability
Defined genomic locus, Reduced clonal variability
Long-term stable expression, Silencing-resistant
Deterministic expression, not random screening
A closed-loop system integrating:
From in silico to in vitro — seamlessly.
For a leading biotech client's stable cell line project
Revived multiple projects that competitors deemed impossible
Cut typical R&D timelines by half for IVD clients